Yufeng Li Selected Research

Arabidopsis vacuolar processing enzyme alpha

4/2008

Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yufeng Li Research Topics

Disease

61	Neoplasms (Cancer) 01/2022 - 03/2006
34	Infections 12/2022 - 04/2006
20	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
12	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2009
11	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2006
10	Virus Diseases (Viral Diseases) 12/2019 - 07/2006
7	Insulin Resistance 12/2021 - 01/2016
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2019 - 07/2013
7	Melanoma (Melanoma, Malignant) 10/2012 - 01/2010
6	Inflammation (Inflammations) 05/2022 - 12/2008
6	COVID-19 01/2022 - 01/2020
5	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 03/2006
5	Ischemic Stroke 05/2022 - 01/2020
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 02/2017
4	Stroke (Strokes) 05/2022 - 07/2017
4	Ischemia 01/2022 - 12/2016
4	Hyperglycemia 01/2021 - 01/2019
4	Body Weight (Weight, Body) 01/2021 - 01/2007
3	Hypoxia (Hypoxemia) 01/2022 - 09/2015
3	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2019
3	Prediabetic State (Prediabetes) 06/2021 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 05/2014
3	Diabetes Mellitus 01/2020 - 03/2018
3	Human Influenza (Influenza) 01/2017 - 04/2013
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2012 - 11/2007
3	Leukemia 10/2012 - 08/2007
3	Glioblastoma (Glioblastoma Multiforme) 10/2010 - 08/2005
2	Hemorrhage 05/2022 - 07/2019
2	Infertility (Sterility) 01/2022 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2014
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 07/2021 - 04/2016
2	Myocardial Infarction 05/2021 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2018

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2006
21	VaccinesIBA 11/2020 - 04/2006
16	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 01/2016
11	Pharmaceutical PreparationsIBA 09/2022 - 01/2009
11	AntigensIBA 07/2021 - 11/2006
9	CytokinesIBA 01/2022 - 01/2009
9	Antiviral Agents (Antivirals)IBA 01/2021 - 08/2005
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2017
6	MicroRNAs (MicroRNA)IBA 05/2022 - 11/2006
6	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2008
6	Insulin (Novolin)FDA Link 01/2021 - 01/2018
6	LigandsIBA 10/2012 - 10/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 04/2011
5	Alanine Transaminase (SGPT)IBA 01/2021 - 08/2005
5	InterferonsIBA 12/2019 - 07/2013
5	HomoharringtonineIBA 10/2019 - 07/2013
5	Messenger RNA (mRNA)IBA 10/2018 - 11/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 10/2008
4	AntibodiesIBA 12/2022 - 03/2011
4	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2018
4	Circular RNAIBA 01/2022 - 01/2020
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 05/2018
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 08/2010
4	Imatinib Mesylate (Gleevec)FDA Link 10/2019 - 06/2016
4	EnzymesIBA 11/2015 - 04/2008
4	HLA Antigens (Human Leukocyte Antigens)IBA 04/2011 - 08/2005
3	InflammasomesIBA 05/2022 - 12/2016
3	hydroxide ionIBA 01/2022 - 10/2009
3	HDL CholesterolIBA 01/2022 - 05/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2012
3	Ferritins (Ferritin)IBA 06/2021 - 02/2017
3	Bevacizumab (Avastin)FDA Link 11/2020 - 08/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 06/2010
3	Antineoplastic Agents (Antineoplastics)IBA 02/2018 - 06/2017
3	Concanavalin AIBA 01/2018 - 01/2016
3	tigatuzumabIBA 06/2015 - 04/2011
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2014 - 06/2010
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2012 - 01/2009
3	Gd@C82(OH)22IBA 12/2010 - 03/2006
3	Peptides (Polypeptides)IBA 08/2009 - 03/2008
3	Small Interfering RNA (siRNA)IBA 03/2008 - 07/2006
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 10/2016
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2018
2	SteroidsIBA 01/2022 - 11/2019
2	Biological ProductsIBA 01/2022 - 12/2006
2	VimentinIBA 01/2022 - 05/2016
2	Uric Acid (Urate)IBA 12/2021 - 01/2019
2	LDL CholesterolIBA 12/2021 - 01/2021
2	oxidized low density lipoproteinIBA 12/2021 - 01/2019
2	Exenatide (Byetta)FDA Link 08/2021 - 01/2021
2	SodiumIBA 05/2021 - 01/2017
2	CholesterolIBA 01/2021 - 05/2018
2	Therapeutic UsesIBA 01/2021 - 01/2016
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 04/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 11/2020
2	AndrogensIBA 01/2021 - 02/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2016
2	GlucokinaseIBA 01/2021 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 03/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 10/2018

Therapy/Procedure

37	Therapeutics 01/2022 - 06/2006
14	Drug Therapy (Chemotherapy) 09/2022 - 06/2010
5	Immunotherapy 01/2022 - 12/2006
2	Stents 05/2022 - 01/2021
2	Aftercare (After-Treatment) 05/2021 - 01/2021